TGX Financial Facts
Income tax expense: 34KSelling, general and administrative: 6.14M
See Full Income Statement
Deferred income tax asset: 997K
Accumulated other comprehensive gain: -1K
See Full Balance Sheet
Theragenics Corp. (TGX) Earnings
|
Expand Research on TGX
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | N/A | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | N/A | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8/8/13 | Q213 | $0.00 | N/A | N/A | $20.3M | $21.96M | N/A | ![]() | ![]() | Details | |
| 2/14/13 |
Q412 | -$0.01 | N/A | N/A | $19.1M | $19.88M | N/A | ![]() | ![]() | Details | |
| 11/8/12 |
Q312 | $0.02 | N/A | N/A | $19.92M | $20.5M | N/A | ![]() | ![]() | Details | |
| 8/9/12 |
Q212 | $0.02 | N/A | N/A | $22M | $21.54M | N/A | ![]() | ![]() | Details | |
| 2/23/12 |
Q411 | $0.01 | N/A | N/A | $19.88M | $20.68M | N/A | ![]() | ![]() | Details | |
| 11/3/11 |
Q311 | $0.03 | N/A | N/A | $20.5M | $20.02M | N/A | ![]() | ![]() | Details | |
| 8/11/11 | Q211 | $0.04 | N/A | N/A | $20.97M | $20.43M | N/A | ![]() | ![]() | Details | |
| 5/5/11 |
Q111 | $0.02 | N/A | N/A | $20.3M | N/A | N/A | ![]() | ![]() | Details |


